Skip to main content

Table 6 Duration until return to normal temperature (efficacy population)

From: Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)

Duration until ≤37.5°C (days)

Total N = 2152 (100%)

n*

(%)

n cum

(%) cum

1

273

(14.4)**

273

(12.7)

2

656

(34.6)**

929

(43.2)

3

557

(29.4)**

1486

(69.1)

4

214

(11.3)**

1700

(79.0)

5

116

(6.1)**

1816

(84.4)

6

30

(1.6)**

1846

(85.8)

7

27

(1.4)**

1873

(87.0)

8

7

(0.4)**

1880

(87.4)

9

5

(0.3)**

1885

(87.6)

10

8

(0.4)**

1893

(88.0)

11

2

(0.1)**

1895

(88.1)

20

1

(0.1)**

1896

(88.1)

No return to normal T

37

(1.7)

1933

(89.8)

Patient not febrile at start

189

(8.8)

  

T not taken continuously

12

(0.6)

  

Missing

19

(0.9)

  

Total

2152

(100.0)

2152

(100.0)

  1. *Multiple responses; **Percentage of total return to normal temperature (n = 1896).
  2. T, temperature.